Stohr R, Reinartz S, Dirrichs T, Witte K, Schuh A, Brandenburg V
Sci Rep. 2024; 14(1):17605.
PMID: 39080305
PMC: 11289316.
DOI: 10.1038/s41598-024-67657-8.
Kaddoura R, Orabi B, Yassin M, Omar A
Rev Cardiovasc Med. 2024; 24(6):180.
PMID: 39077529
PMC: 11264133.
DOI: 10.31083/j.rcm2406180.
Hasific S, Oevrehus K, Lindholt J, Mejldal A, Dey D, Dahl J
JACC Adv. 2024; 2(9):100643.
PMID: 38938724
PMC: 11198368.
DOI: 10.1016/j.jacadv.2023.100643.
Al Said S, Kaier K, Sumaya W, Alsaid D, Duerschmied D, Storey R
Cochrane Database Syst Rev. 2024; 1:CD014678.
PMID: 38264795
PMC: 10806408.
DOI: 10.1002/14651858.CD014678.pub2.
Sarraju A, Nissen S
Nat Rev Cardiol. 2024; 21(7):487-497.
PMID: 38177454
DOI: 10.1038/s41569-023-00979-8.
Interventions to Attenuate Cardiovascular Calcification Progression: A Systematic Review of Randomized Clinical Trials.
Murali S, Smith E, Tiong M, Tan S, Toussaint N
J Am Heart Assoc. 2023; 12(23):e031676.
PMID: 38014685
PMC: 10727339.
DOI: 10.1161/JAHA.123.031676.
Direct Oral Anticoagulants as the First Choice of Anticoagulation for Patients with Peripheral Artery Disease to Prevent Adverse Vascular Events: A Systematic Review and Meta-Analysis.
Pomozi E, Nagy R, Fehervari P, Hegyi P, Kiss B, Dembrovszky F
J Cardiovasc Dev Dis. 2023; 10(2).
PMID: 36826561
PMC: 9964590.
DOI: 10.3390/jcdd10020065.
Vitamin K antagonists and cardiovascular calcification: A systematic review and meta-analysis.
Kosciuszek N, Kalta D, Singh M, Savinova O
Front Cardiovasc Med. 2022; 9:938567.
PMID: 36061545
PMC: 9437425.
DOI: 10.3389/fcvm.2022.938567.
Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism.
Stohr R, Dirrichs T, Kneizeh K, Reinartz S, Frank D, Brachmann J
Clin Cardiol. 2022; 45(4):352-358.
PMID: 35332571
PMC: 9019879.
DOI: 10.1002/clc.23819.
Warfarin involvement, in comparison to NOACs, in the development of systemic atherosclerosis.
Mihaila R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022; 166(2):150-154.
PMID: 35228757
DOI: 10.5507/bp.2022.008.
Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part II.
Pontone G, Rossi A, Guglielmo M, Dweck M, Gaemperli O, Nieman K
Eur Heart J Cardiovasc Imaging. 2022; 23(4):e136-e161.
PMID: 35175348
PMC: 8944330.
DOI: 10.1093/ehjci/jeab292.
Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication.
Kim J, Hwang H
Korean Circ J. 2021; 51(12):961-982.
PMID: 34854578
PMC: 8636761.
DOI: 10.4070/kcj.2021.0995.
The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review.
Elango K, Javaid A, Khetarpal B, Ramalingam S, Kolandaivel K, Gunasekaran K
Cells. 2021; 10(4).
PMID: 33807457
PMC: 8066517.
DOI: 10.3390/cells10040773.
A narrative review of low-dose rivaroxaban in patients with atherothrombotic cardiovascular disease: vascular protection beyond anticoagulation.
Rocha B, da Cunha G, Aguiar C
Cardiovasc Diagn Ther. 2021; 11(1):130-141.
PMID: 33708485
PMC: 7944201.
DOI: 10.21037/cdt-20-859.
Extent of arterial calcification by conventional vitamin K antagonist treatment.
Hasific S, Ovrehus K, Gerke O, Hallas J, Busk M, Lambrechtsen J
PLoS One. 2020; 15(10):e0241450.
PMID: 33119722
PMC: 7595268.
DOI: 10.1371/journal.pone.0241450.
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
Budoff M, Bhatt D, Kinninger A, Lakshmanan S, Muhlestein J, Le V
Eur Heart J. 2020; 41(40):3925-3932.
PMID: 32860032
PMC: 7654934.
DOI: 10.1093/eurheartj/ehaa652.
Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.
Olie R, van der Meijden P, Spronk H, ten Cate H
Handb Exp Pharmacol. 2020; 270:103-130.
PMID: 32776281
DOI: 10.1007/164_2020_357.
A review of serial coronary computed tomography angiography (CTA) to assess plaque progression and therapeutic effect of anti-atherosclerotic drugs.
Taron J, Lee S, Aluru J, Hoffmann U, Lu M
Int J Cardiovasc Imaging. 2020; 36(12):2305-2317.
PMID: 32076919
PMC: 7434668.
DOI: 10.1007/s10554-020-01793-w.
